Eli Lilly & Co. (LLY) Social Stream



Eli Lilly & Co. (LLY): $867.30

1.48 (+0.17%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

ELI LILLY & CO (LLY) Price Targets From Analysts

Use the tables below to see what analysts covering ELI LILLY & CO think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-27 12 $315 $183 $272.666 $614.5 -55.63%
2021-11-19 12 $315 $183 $275.615 $614.5 -55.15%
2021-12-08 12 $315 $183 $278.615 $614.5 -54.66%
2021-12-15 13 $315 $250 $285.307 $614.5 -53.57%
2021-12-16 13 $335 $250 $290.615 $614.5 -52.71%
2021-12-20 13 $335 $265 $299.076 $614.5 -51.33%
2022-01-12 13 $335 $265 $299.846 $614.5 -51.2%
2022-02-04 12 $335 $265 $299.846 $614.5 -51.2%
2022-02-14 12 $335 $265 $299.307 $614.5 -51.29%
2022-02-24 12 $335 $265 $298.615 $614.5 -51.41%
2022-03-10 12 $335 $265 $297.714 $614.5 -51.55%
2022-03-17 12 $335 $265 $298.785 $614.5 -51.38%
2022-04-18 12 $364 $265 $305.857 $614.5 -50.23%
2022-04-29 11 $369 $265 $312.642 $614.5 -49.12%
2022-05-10 12 $369 $265 $321.714 $614.5 -47.65%
2022-05-25 13 $369 $264 $319.312 $614.5 -48.04%
2022-06-15 13 $369 $264 $320.25 $614.5 -47.88%
2022-07-22 14 $395 $264 $329.062 $614.5 -46.45%
2022-08-05 13 $395 $264 $330.625 $614.5 -46.2%
2022-08-24 14 $395 $264 $331 $614.5 -46.14%
2022-08-31 14 $395 $264 $337.562 $614.5 -45.07%
2022-09-07 14 $396 $264 $342.312 $614.5 -44.29%
2022-09-21 14 $412 $264 $344.312 $614.5 -43.97%
2022-09-28 15 $412 $264 $345.411 $614.5 -43.79%
2022-10-31 14 $408 $264 $347.529 $614.5 -43.45%
2022-11-02 14 $408 $264 $351.058 $614.5 -42.87%
2022-11-08 14 $441 $286 $368.058 $614.5 -40.1%
2022-11-15 14 $441 $286 $369.294 $614.5 -39.9%
2022-11-16 15 $436 $286 $369 $614.5 -39.95%
2022-11-30 15 $436 $286 $373.117 $614.5 -39.28%
2022-12-06 16 $436 $286 $375.47 $614.5 -38.9%
2022-12-08 16 $446 $286 $378 $614.5 -38.49%
2022-12-13 16 $446 $286 $381.611 $614.5 -37.9%
2022-12-14 16 $446 $286 $382.722 $614.5 -37.72%
2022-12-16 16 $446 $286 $383.722 $614.5 -37.56%
2023-01-19 16 $446 $286 $384 $614.5 -37.51%
2023-02-01 16 $446 $286 $389.47 $614.5 -36.62%
2023-02-03 16 $446 $286 $388.588 $614.5 -36.76%
2023-02-27 16 $455 $286 $389.117 $614.5 -36.68%
2023-03-03 17 $444 $286 $387.882 $614.5 -36.88%
2023-03-06 18 $444 $290 $388.117 $614.5 -36.84%
2023-03-31 18 $444 $310 $390.176 $614.5 -36.51%
2023-04-05 18 $444 $313 $393.562 $614.5 -35.95%
2023-04-10 18 $448 $313 $393.812 $614.5 -35.91%
2023-04-11 18 $448 $313 $393.25 $614.5 -36%
2023-04-27 18 $445 $313 $393.062 $614.5 -36.04%
2023-04-28 18 $485 $313 $407.875 $614.5 -33.62%
2023-05-01 18 $485 $313 $412.125 $614.5 -32.93%
2023-05-03 18 $485 $313 $417.75 $614.5 -32.02%
2023-05-15 18 $505 $313 $427.375 $614.5 -30.45%
2023-05-23 18 $507 $313 $429.187 $614.5 -30.16%
2023-05-24 18 $507 $313 $436.687 $614.5 -28.94%
2023-06-13 18 $507 $313 $440.437 $614.5 -28.33%
2023-06-27 18 $507 $313 $450 $614.5 -26.77%
2023-06-28 18 $550 $313 $454.062 $614.5 -26.11%
2023-07-11 18 $551 $313 $461.812 $614.5 -24.85%
2023-07-18 18 $560 $313 $467.588 $614.5 -23.91%
2023-07-21 18 $565 $313 $477.235 $614.5 -22.34%
2023-07-26 18 $565 $313 $488.235 $614.5 -20.55%
2023-07-28 18 $565 $313 $487.352 $614.5 -20.69%
2023-08-09 18 $633 $392 $558.47 $614.5 -9.12%
2023-09-07 18 $640 $392 $569.529 $614.5 -7.32%
2023-10-05 18 $640 $392 $577.47 $614.5 -6.03%
2023-10-09 18 $700 $392 $583.941 $614.5 -4.97%
2023-10-17 18 $700 $392 $587.941 $614.5 -4.32%
2023-10-21 18 $700 $470 $609.294 $614.5 -0.85%
2023-11-03 18 $722 $470 $624.117 $614.5 1.57%
2023-11-08 18 $722 $470 $627.352 $614.5 2.09%
2023-11-10 19 $722 $470 $622.222 $614.5 1.26%
2023-11-15 19 $722 $470 $624.333 $614.5 1.6%
2023-12-05 19 $722 $470 $629.888 $614.5 2.5%
2023-12-12 19 $722 $470 $634.333 $614.5 3.23%
2023-12-18 18 $727 $470 $634.882 $614.5 3.32%
2023-12-27 19 $727 $470 $634.882 $614.5 3.32%
2023-12-29 20 $727 $470 $633.5 $614.5 3.09%

The Trend in the Analyst Price Target


LLY's average price target has moved up $472.92 over the prior 45 months.

Over the past 50 weeks, LLY's average upside potential has been 6.45%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-01 16 446 286 389.470 342.57 13.69%
2023-06-21 18 507 313 450.000 453.00 -0.66%
2023-07-11 18 551 313 461.812 439.39 5.1%
2023-11-13 19 722 470 624.333 612.71 1.9%
2023-11-22 19 722 470 629.888 595.09 5.85%

LLY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.23 17 1 2 0 0 20

The Trend in the Broker Recommendations


Over the past 45 months, LLY's average broker recommendation rating improved by 0.74.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ELI LILLY & CO's average analyst price target is higher than 9585.11% of all US stocks.
  • In the context of Healthcare stocks, ELI LILLY & CO's upside potential (average analyst target price relative to current price) is greater than 444.95% of them.
  • ELI LILLY & CO's number of analysts covering the stock is greater than 8726.44% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ELI LILLY & CO's variance in analysts' estimates is lower than -2380.89% of them.

In the Pharmaceutical Products industry, ABT, BNTX, and MRNA are the three stocks most similar to ELI LILLY & CO regarding the price target and analyst recommendation information presented here.

What is the outlook for LLY? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!